Cellectis (CLLS) Goodwill & Intangibles (2014 - 2026)
Cellectis (CLLS) recorded quarterly Goodwill & Intangibles of $221000.0 in Q1 2026, down 58.69% quarter-over-quarter from $535000.0 in Q4 2025, and down 8.68% on a YoY basis from $242000.0 in Q1 2025.
Cellectis (CLLS) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
Cellectis' Goodwill & Intangibles history runs 13 years deep, the most recent figure standing at $221000.0 for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 8.68% year-over-year to $221000.0; the TTM figure through Mar 2026 stood at $221000.0 (down 8.68% YoY), while the FY2025 annual figure was $535000.0, down 52.06% from the prior year.
- Goodwill & Intangibles was $221000.0 for Q1 2026 at Cellectis, down from $535000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $1.7 million in Q1 2022 to a low of $221000.0 in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $846176.5 across 5 years, with a median of $695000.0 in 2023.
- Biggest YoY gain for Goodwill & Intangibles was 76.57% in 2025; the steepest drop was 64.25% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $718000.0 in 2022, then retreated by 6.55% to $671000.0 in 2023, then soared by 66.32% to $1.1 million in 2024, then plunged by 52.06% to $535000.0 in 2025, then slumped by 58.69% to $221000.0 in 2026.
- The last three Goodwill & Intangibles figures came in at $221000.0 (Q1 2026), $535000.0 (Q4 2025), and $845000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 242,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 691,000.00 |
| Jun 30, 2024 | 653,000.00 |
| Mar 31, 2024 | 677,000.00 |
| Dec 31, 2023 | 671,000.00 |
| Sep 30, 2023 | 662,000.00 |
| Jun 30, 2023 | 695,000.00 |
| Mar 31, 2023 | 713,000.00 |
| Dec 31, 2022 | 718,000.00 |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 2.55 Mn |
| Jun 30, 2021 | 1.58 Mn |